XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock (Class A, B and Exchangeable)
Additional Paid-in-Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   191,022,864    
Beginning balance at Dec. 31, 2022 $ 485,806 $ 2 $ 1,125,360 $ (639,556)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Comprehensive loss (65,327)     (65,327)
Stock option exercises and other (in shares)   1,207,990    
Stock option exercises and other 882   882  
Stock-based compensation 8,814   8,814  
Ending balance (in shares) at Mar. 31, 2023   192,230,854    
Ending balance at Mar. 31, 2023 $ 430,175 $ 2 1,135,056 (704,883)
Beginning balance (in shares) at Dec. 31, 2023 234,270,384 234,270,384    
Beginning balance at Dec. 31, 2023 $ 463,436 $ 2 1,431,056 (967,622)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Comprehensive loss $ (91,373)     (91,373)
Stock option exercises and other (in shares) 1,303,878 2,317,083    
Stock option exercises and other $ 2,088   2,088  
Stock-based compensation 16,127   16,127  
Common stock sales issuances, net of issuance costs (in shares)   921,215    
Common stock sales issuances, net of issuance costs $ 10,873   10,873  
Ending balance (in shares) at Mar. 31, 2024 237,508,682 237,508,682    
Ending balance at Mar. 31, 2024 $ 401,151 $ 2 $ 1,460,144 $ (1,058,995)